Dosimetric effects of source-offset in intravascular brachytherapy

被引:13
作者
Chibani, O [1 ]
Li, XA [1 ]
机构
[1] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA
关键词
intravascular brachytherapy; Monte Carlo dosimetry; source offset; source centering;
D O I
10.1118/1.1461373
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
In intravascular brachytherapy (IVBT), radioactive sources can he displaced (offset) laterally from the center of the lumen and/or longitudinally from the desired location due to the cardiac motion and/or the absence of a source-centerin g device. The purpose of this work is to study the dosimetric impact of such a source offset. Dose effects of both lateral and longitudinal source offsets with or without the presence of a calcified plaque or a metallic stent are calculated for the three most commonly used sources (P-32, Sr-90/Y-90, and Ir-192). The MCNP Monte Carlo code is used in the calculation. Static and random source offsets are considered. The major result,, include that W) dose can be changed significantly (by a factor of up to 4) due to a static lateral source offset: (b) this dose variation is reduced if the lateral source offset is considered as random moving within the vessel (the dose at the 2 mm reference radial distance is increased by 5-15% for the three sources ill the case of the 2D random offset studied) (c) the presence of a calcified plaque and/or a Metallic stent worsens the dosimetric effects: (d) the longitudinal random source offset results ill a reduction (15-18%) in the effective treatment length: (e) the dose effects of source offsets for the beta source are higher than those for the gamma source. The data presented in this paper may be used for IVBT treatment planning or for dosimetric analysis of treatment outcome. The dose change due to the source offset should be considered in dose prescription. The reduction of effective treatment length should be taken into account in selection of a proper Source length to ensure all adequate coverage of the treatment target. (C) 2002 American Association of Physicist. in Medicine.
引用
收藏
页码:530 / 537
页数:8
相关论文
共 31 条
[1]
Intracoronary radiation for prevention of restenosis - Dose perturbations caused by stents [J].
Amols, HI ;
Trichter, F ;
Weinberger, J .
CIRCULATION, 1998, 98 (19) :2024-2029
[2]
Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries [J].
Amols, HI ;
Zaider, M ;
Weinberger, J ;
Ennis, R ;
Schiff, PB ;
Reinstein, LE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04) :913-921
[3]
Dose rate table for a 32P intravascular brachytherapy source from Monte Carlo calculations [J].
Bohm, TD ;
Mourtada, FA ;
Das, RK .
MEDICAL PHYSICS, 2001, 28 (08) :1770-1775
[4]
Briesmeister J.F., 2000, LA13709M LOS AL NAT
[5]
CROCKER I, 1999, J INTERV CARD ELECTR, V12, P274
[6]
DIAP HB, 2001, INT J RADIAT ONCOL, V49, P273
[7]
Radiochromic film dosimetry of a high dose rate beta source for intravascular brachytherapy [J].
Duggan, DM ;
Coffey, CW ;
Lobdell, JL ;
Schell, MC .
MEDICAL PHYSICS, 1999, 26 (11) :2461-2464
[8]
Fan, 2001, Cardiovasc Radiat Med, V2, P18, DOI 10.1016/S1522-1865(00)00039-1
[9]
GLASGOW G P, 1979, Medical Physics (Woodbury), V6, P49, DOI 10.1118/1.594551
[10]
King III SB, 1995, DISCOVERIES RAD REST